Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms

Ronald W. Millard, David A. Lathrop, Gunter Grupp, Muhammad Ashraf, Ingrid L. Grupp, Arnold Schwartz

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

The three major calcium channel blocking agents, diltiazem, nifedipine and verapamil, inhibit calcium entry into excitable cells. Despite this apparent common action at the cell membrane, these drugs produce quantitative and frequently qualitative differences in cardiovascular variables (for example, heart rate, atrioventricular [A-V] conduction and myocardial inotropic state) when evaluated at equieffective vasodilator doses. All three drugs increase coronary blood flow in a dose-dependent fashion (nifedipine > diltiazem = verapamil), and produce a negative inotropic effect in vitro in isolated atria and ventricles, also in a dose-dependent manner (verapamil > nifedipine > diltiazem). However, in conscious dogs nifedipine increases, verapamil decreases and diltiazem has little effect on the inotropic state. A-V conduction is slowed by diltiazem and verapamil but not by nifedipine in anesthetized dogs and in conscious dogs as judged from the P-R interval in the electrocardiogram. Heart rate is slowed in pentobarbital-anesthetized animals but is accelerated in conscious dogs (nifedipine > verapamil > diltiazem). Nifedipine also appears to interfere significantly with the arterial baroreceptor reflex by an apparent vagolytic action that is less evident with diltiazem and verapamil. Diltiazem, and possibly verapamil and nifedipine as well, appears to retard myocardial damage that accompanies ischemia. The mechanisms and sites of action of these drugs are presumed to be at the cell membrane; however, intracellular sites may also be involved.

Original languageEnglish (US)
Pages (from-to)499-506
Number of pages8
JournalThe American Journal of Cardiology
Volume49
Issue number3
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Diltiazem
Calcium Channels
Nifedipine
Verapamil
Dogs
Heart Rate
Cell Membrane
Pharmaceutical Preparations
Baroreflex
Pentobarbital
Vasodilator Agents
Electrocardiography
Ischemia
Calcium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Differential cardiovascular effects of calcium channel blocking agents : Potential mechanisms. / Millard, Ronald W.; Lathrop, David A.; Grupp, Gunter; Ashraf, Muhammad; Grupp, Ingrid L.; Schwartz, Arnold.

In: The American Journal of Cardiology, Vol. 49, No. 3, 01.01.1982, p. 499-506.

Research output: Contribution to journalArticle

Millard, Ronald W. ; Lathrop, David A. ; Grupp, Gunter ; Ashraf, Muhammad ; Grupp, Ingrid L. ; Schwartz, Arnold. / Differential cardiovascular effects of calcium channel blocking agents : Potential mechanisms. In: The American Journal of Cardiology. 1982 ; Vol. 49, No. 3. pp. 499-506.
@article{da56730f064546bc906ac46febc1107c,
title = "Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms",
abstract = "The three major calcium channel blocking agents, diltiazem, nifedipine and verapamil, inhibit calcium entry into excitable cells. Despite this apparent common action at the cell membrane, these drugs produce quantitative and frequently qualitative differences in cardiovascular variables (for example, heart rate, atrioventricular [A-V] conduction and myocardial inotropic state) when evaluated at equieffective vasodilator doses. All three drugs increase coronary blood flow in a dose-dependent fashion (nifedipine > diltiazem = verapamil), and produce a negative inotropic effect in vitro in isolated atria and ventricles, also in a dose-dependent manner (verapamil > nifedipine > diltiazem). However, in conscious dogs nifedipine increases, verapamil decreases and diltiazem has little effect on the inotropic state. A-V conduction is slowed by diltiazem and verapamil but not by nifedipine in anesthetized dogs and in conscious dogs as judged from the P-R interval in the electrocardiogram. Heart rate is slowed in pentobarbital-anesthetized animals but is accelerated in conscious dogs (nifedipine > verapamil > diltiazem). Nifedipine also appears to interfere significantly with the arterial baroreceptor reflex by an apparent vagolytic action that is less evident with diltiazem and verapamil. Diltiazem, and possibly verapamil and nifedipine as well, appears to retard myocardial damage that accompanies ischemia. The mechanisms and sites of action of these drugs are presumed to be at the cell membrane; however, intracellular sites may also be involved.",
author = "Millard, {Ronald W.} and Lathrop, {David A.} and Gunter Grupp and Muhammad Ashraf and Grupp, {Ingrid L.} and Arnold Schwartz",
year = "1982",
month = "1",
day = "1",
doi = "10.1016/S0002-9149(82)80002-7",
language = "English (US)",
volume = "49",
pages = "499--506",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Differential cardiovascular effects of calcium channel blocking agents

T2 - Potential mechanisms

AU - Millard, Ronald W.

AU - Lathrop, David A.

AU - Grupp, Gunter

AU - Ashraf, Muhammad

AU - Grupp, Ingrid L.

AU - Schwartz, Arnold

PY - 1982/1/1

Y1 - 1982/1/1

N2 - The three major calcium channel blocking agents, diltiazem, nifedipine and verapamil, inhibit calcium entry into excitable cells. Despite this apparent common action at the cell membrane, these drugs produce quantitative and frequently qualitative differences in cardiovascular variables (for example, heart rate, atrioventricular [A-V] conduction and myocardial inotropic state) when evaluated at equieffective vasodilator doses. All three drugs increase coronary blood flow in a dose-dependent fashion (nifedipine > diltiazem = verapamil), and produce a negative inotropic effect in vitro in isolated atria and ventricles, also in a dose-dependent manner (verapamil > nifedipine > diltiazem). However, in conscious dogs nifedipine increases, verapamil decreases and diltiazem has little effect on the inotropic state. A-V conduction is slowed by diltiazem and verapamil but not by nifedipine in anesthetized dogs and in conscious dogs as judged from the P-R interval in the electrocardiogram. Heart rate is slowed in pentobarbital-anesthetized animals but is accelerated in conscious dogs (nifedipine > verapamil > diltiazem). Nifedipine also appears to interfere significantly with the arterial baroreceptor reflex by an apparent vagolytic action that is less evident with diltiazem and verapamil. Diltiazem, and possibly verapamil and nifedipine as well, appears to retard myocardial damage that accompanies ischemia. The mechanisms and sites of action of these drugs are presumed to be at the cell membrane; however, intracellular sites may also be involved.

AB - The three major calcium channel blocking agents, diltiazem, nifedipine and verapamil, inhibit calcium entry into excitable cells. Despite this apparent common action at the cell membrane, these drugs produce quantitative and frequently qualitative differences in cardiovascular variables (for example, heart rate, atrioventricular [A-V] conduction and myocardial inotropic state) when evaluated at equieffective vasodilator doses. All three drugs increase coronary blood flow in a dose-dependent fashion (nifedipine > diltiazem = verapamil), and produce a negative inotropic effect in vitro in isolated atria and ventricles, also in a dose-dependent manner (verapamil > nifedipine > diltiazem). However, in conscious dogs nifedipine increases, verapamil decreases and diltiazem has little effect on the inotropic state. A-V conduction is slowed by diltiazem and verapamil but not by nifedipine in anesthetized dogs and in conscious dogs as judged from the P-R interval in the electrocardiogram. Heart rate is slowed in pentobarbital-anesthetized animals but is accelerated in conscious dogs (nifedipine > verapamil > diltiazem). Nifedipine also appears to interfere significantly with the arterial baroreceptor reflex by an apparent vagolytic action that is less evident with diltiazem and verapamil. Diltiazem, and possibly verapamil and nifedipine as well, appears to retard myocardial damage that accompanies ischemia. The mechanisms and sites of action of these drugs are presumed to be at the cell membrane; however, intracellular sites may also be involved.

UR - http://www.scopus.com/inward/record.url?scp=0020425810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020425810&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(82)80002-7

DO - 10.1016/S0002-9149(82)80002-7

M3 - Article

C2 - 6277175

AN - SCOPUS:0020425810

VL - 49

SP - 499

EP - 506

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 3

ER -